- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies | ||
| Mi | Merck KGaA looks to M&A to bolster its 'rather slim' pipeline | ||
| Di | FDA Commissioner Marty Makary to resign, capping turbulent tenure: report | ||
| Di | Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report | ||
| Di | Alkermes' Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition | ||
| Di | As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT | ||
| Di | Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu | ||
| Di | Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition | ||
| Di | EU advances scheme to bolster manufacturing autonomy, avert drug shortages | ||
| Di | Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer | ||
| 11.05. | CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion | ||
| 11.05. | Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer | ||
| 11.05. | Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan | ||
| 11.05. | OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint | ||
| 11.05. | Eli Lilly shoots for health in new Caitlin Clark ad campaign | ||
| 08.05. | Targeted Protein Degradation and Novel Modalities: Getting on the Frontline | ||
| 08.05. | Trump plans to fire FDA chief Marty Makary: report | ||
| 08.05. | Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill | ||
| 08.05. | Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma | ||
| 08.05. | Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory' | ||
| 08.05. | Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild | ||
| 08.05. | AbbVie's Skyrizi beats out J&J's Tremfya in in April drug ad spending leaderboard | ||
| 08.05. | Johnson & Johnson launches 'Generation Fine' depression project | ||
| 08.05. | Revisiting Pharma's tariff reality | ||
| 08.05. | GSK tees up a Modern Family for meningitis messaging |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.